MS Clinical Trials in Minnesota
18 active trials · 9 recruiting
18 active multiple sclerosis clinical trials have at least one study site in Minnesota, 9 of them currently recruiting participants. Trials are listed from ClinicalTrials.gov and cover disease-modifying therapies, symptom treatments, rehabilitation and imaging studies.
Eligibility, contact details and the exact site address are on each trial's ClinicalTrials.gov record, linked from every trial page. MS Buddy also lists 8 MS treatment centers in Minnesota; many trial sites are run from those centers, and your neurologist is the best first person to ask about joining a study.
Active MS trials with sites in Minnesota
RecruitingPhase 3
Study to Evaluate Safety, Efficacy and Pharmacokinetics (PK) of a Modified Regimen of Ublituximab
Sponsor: TG Therapeutics, Inc.
Ublituximab · Placebo
25 states800 participantsDetails ›
RecruitingNA
The SetPoint System as a Pro-Remyelination Therapy for Relapsing-Remitting Multiple Sclerosis: A Pilot Study
Sponsor: SetPoint Medical Corporation
Procedure/Surgery: Implant Procedure · Disease-Modifying Therapies (DMTs)
4 states60 participantsDetails ›
RecruitingPhase 3
Efficacy and Safety Studies of Frexalimab (SAR441344) in Adults With Relapsing Forms of Multiple Sclerosis
Sponsor: Sanofi
Frexalimab · Teriflunomide
35 states1600 participantsDetails ›
RecruitingNA
Deciphering Preserved Autonomic Function After Multiple Sclerosis
Sponsor: Mayo Clinic
Tests of sympathetic inhibition · Tests of sympathetic activation
1 state13 participantsDetails ›
RecruitingPhase 3
Efficacy and Safety Study of Frexalimab (SAR441344) in Adults With Nonrelapsing Secondary Progressive Multiple Sclerosis
Sponsor: Sanofi
Frexalimab · Placebo
38 states900 participantsDetails ›
Recruiting
Study to Evaluate the Usability and Value of Integrated Digital Solutions in Medical Care of Participants With Multiple Sclerosis
Sponsor: Hoffmann-La Roche
MS Care Platform (icobrain ms and ico…
2 states500 participantsDetails ›
RecruitingPhase 3
Best Available Therapy Versus Autologous Hematopoietic Stem Cell Transplant for Multiple Sclerosis (BEAT-MS)
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Autologous Hematopoietic Stem Cell Tr… · Best Available Therapy (BAT)
15 states156 participantsDetails ›
RecruitingNA
Breathing Practice for Brain and Mental Health in Cancer and Neurodegenerative Diseases
Sponsor: Mayo Clinic
Biospecimen Collection · Exercise Intervention
1 state147 participantsDetails ›
Recruiting
A Study to Learn More About The Safety of Diroximel Fumarate (VUMERITY®) in Participants Who Took it During Pregnancy And About the Health of Their Babies
Sponsor: Biogen
Diroximel Fumarate · Alemtuzumab
1 state1178 participantsDetails ›
By invitation onlyPhase 2
A Study of Imaging in Demyelinating Diseases
Sponsor: Mayo Clinic
C-11 ER176 Radiotracer · C11 Pittsburgh Compound B
1 state200 participantsDetails ›
Closed to new patientsPhase 3
A Study to Evaluate the Efficacy and Safety of Fenebrutinib Compared With Ocrelizumab in Adult Participants With Primary Progressive Multiple Sclerosis
Sponsor: Hoffmann-La Roche
Fenebrutinib · Ocrelizumab
24 states985 participantsDetails ›
Closed to new patientsPhase 3
Long-term Safety, Tolerability and Effectiveness Study of Ofatumumab in Patients With Relapsing MS
Sponsor: Novartis Pharmaceuticals
Ofatumumab · Tetanus toxoid (TT) containing vaccin…
32 states1882 participantsDetails ›
Closed to new patientsPhase 3
A Study to Investigate Long-term Safety and Tolerability of Tolebrutinib in Participants With Multiple Sclerosis.
Sponsor: Sanofi
Tolebrutinib · Placebo
27 states2500 participantsDetails ›
Closed to new patientsPhase 3
A Rollover Study to Evaluate the Long-Term Safety and Efficacy of Ocrelizumab In Patients With Multiple Sclerosis
Sponsor: Hoffmann-La Roche
Ocrelizumab
26 states1300 participantsDetails ›
Closed to new patientsPhase 2
A Study of Obexelimab in Patients With Relapsing Multiple Sclerosis (MoonStone)
Sponsor: Zenas BioPharma (USA), LLC
Obexelimab · Placebo
11 states93 participantsDetails ›
Closed to new patientsNA
Traditional Versus Early Aggressive Therapy for Multiple Sclerosis Trial
Sponsor: Johns Hopkins University
Natalizumab/natalizumab-sztn, Alemtuz… · Glatiramer acetate, Interferons (intr…
28 states900 participantsDetails ›
Closed to new patientsPhase 4
Determining the Effectiveness of earLy Intensive Versus Escalation Approaches for RRMS
Sponsor: The Cleveland Clinic
Early Highly Effective Therapies Group · Escalation Therapies Group
8 states800 participantsDetails ›
Closed to new patients
A Study to Evaluate the Safety of Ozanimod Exposure During Pregnancy in Women With Multiple Sclerosis and Their Infants
Sponsor: Bristol-Myers Squibb
Ozanimod · Select DMTs other than ozanimod
1 state2961 participantsDetails ›
MS trials in other states
The app
Check out the MS Buddy app
Track symptoms, monitor wellness, and stay on top of your MS care. It’s free, with no ads. Built by people living with MS.